Karsinoma Sel Skuamosa Paru Kanan Dengan PPOK Dan Atelektasis  Paru Kiri

Nurul Muna; Indra Buana

doi:10.55606/detector.v2i1.3140

Authors

Nurul Muna Universitas Malikussaleh
Indra Buana RSUD Cut Meutia

DOI:

https://doi.org/10.55606/detector.v2i1.3140

Keywords:

Cancer, Lungs, COPD, Atelectasis, Chemotherapy

Abstract

Lung cancer is one of the most common causes of death today. One case of right lung squamous cell carcinoma with COPD and atelectasis has been reported in a 44 year old male patient. Based on the history, the patient said he had experienced chest pain for 1 week before entering the hospital and had a cough without phlegm or blood. Physical examination revealed dull chest wall percussion at the apex of the right lung and dullness in the left lung field, vesicular breathing sounds in both lung fields and rhonchi in the left lung field. The results of the supporting examination found a mass in the left lung on a chest x-ray and a bronchoscopy examination found a right lung tumor (type?) T3N1M0 Stage IIIA and the results of the anatomical pathology examination showed a picture of non-small cell carcinoma type squamous cell carcinoma. Patients are treated with chemotherapy and symptomatic therapy.

References

Morrissey K, Yuraszeck T, Li C, Zhang Y, Kasichayanula S. Immunotherapy and novel combinations in oncology: current landscape, challenges, and opportuni-ties. Clin Transl Sci. 2016;9(2):89–104.

Cancer Indonesia. Global Cancer Observatory (GLOBOCAN) [Internet]. 2018. Available from: https://gco.iarc.fr

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Zulkifli A. Kanker Paru. In: Buku Ajar Ilmu Penyakit Dalam Jilid III (6th ed). Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam; 2014.

Komite Penanggulangan Kanker Nasional. Panduan Praktik Klinis Kanker Paru. 2015.

Oktaviyanti IK. Mutasi egfr pada pemeriksaan sitologi adenokarsinoma paru. Berk Kedokt. 2015;11(2):213–9.

Komite Penanggulangan Kanker Nasional. Pedoman Nasional Pelayanan Kedokteran Kanker Paru. Jakarta: Kementerian Kesehatan Nasional; 2017.

Wouters E. Chronic Obstructive Pulmonary Disease: Systemic Effect of COPD. Thorax. 2002;57:1067–70.

Agusti A, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic Effects of Chronic Obstructive Pulmonary Disease. Eur Respir J. 2003;21(2):347–60.

Grott K, Chauhan S. Atelectasis [Internet]. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545316/

Putra MA. Karakteristik Penderita Kanker Paru di Rumah Sakit Wahidin Sudirohusodo Makassar Periode Januari Desember 2016. Univ Hasanudin. 2017;

Lisa TG, Saad A S. Profil Penderita Penyakit Paru Obstruktif Kronik (PPOK) yang Dirawat Inap di RSUD Arifin Achmad Provinsi Riau Tahun 2013. J Online Mhs Fak Kedokt Univ Riau. 2015;1(2).

Pranyaandara IGBMA, et al. Karakteristik Pasien Karsinoma Paru di RSUP Sanglah Denpasar Tahun 2017-2018. J Med Udayana. 2020;9(11):43–50.

Bordoni B, Marelli F, Morabito B CR. Chest Pain in Patients with COPD: The Fascia’s Subtle Silence. Int J COPD. 2018;13:1157–65.

Perhimpunan dokter paru Indonesia. Kanker Paru Pedoman Diagnosis dan Penatalaksanaan di Indonesia. Jakarta; 2003.